Drug Type Small molecule drug |
Synonyms JS-104 |
Target |
Mechanism CDK inhibitors(Cyclin-dependent kinase (CDK) family inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | - | 19 Oct 2020 |